Evidence map›Paper›PMID 37074514›Full record

ArticleMagma (New York, N.Y.)2023

Preparation of MnO

Saba Ziyaee, Reza Malekzadeh, Marjan Ghorbani, Behnam Nasiri Motlagh, Vahid Asghariazar, Tohid Mortezazadeh

Abstract read
PubMed Publisher
In one paragraph

Article in Magma (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Saba ZiyaeeDepartment of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Reza MalekzadehDepartment of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Marjan GhorbaniNutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Behnam Nasiri MotlaghDepartment of Radio-Oncology, Shahid Madani Hospital, Tabriz, Iran.
Vahid AsghariazarCancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Tohid MortezazadehDepartment of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. tmortezazadeh@gmail.com.
Tabriz University of Medical Sciences · IRArdabil University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA novel efficient pH-sensitive targeted magnetic resonance imaging (MRI) contrast agent and innovative radio-sensitizing system were synthesized based on MnO MATERIALS AND

methodsThe as-established NPs were fully characterized and evaluated for MRI signal enhancement, relaxivity, in vitro cell targeting, cell toxicity, blood compatibility, and radiotherapy (RT) efficacy.

resultsThe targeted NPs MnO

conclusionWe draw the conclusion that using MnO

Indexed as

Breast NeoplasmsNanoparticlesCell Line, TumorContrast MediaFemaleHumansMagnetic Resonance ImagingManganese CompoundsMethacrylatesMethotrexateOxides2-(dimethylamino)ethyl methacrylateContrast MediaManganese CompoundsMethacrylatesMethotrexateOxidesMagnetic resonance imagingManganese dioxideNanoparticleRadiation therapy

Identifiers

PMID37074514
OpenAlexW4366352727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.